nanoPET Tracers - Novel Nanoparticulate Tracers for Clinical Positron Emission Tomography (PET)

As an addition to the pre-clinical portfolio, nanoPET plans to clinically develop its patented technology: Inorganic nanoparticular tracers for cell- and molecular-specific positron emission tomography (PET). nanoPET Pharma has recently been awarded 0.74 milion EUR in funding by the German Federal Ministry of Education and Research (BMBF) to boost pre-clinical development of the myocarditis tracer.